{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:10:33Z","timestamp":1793949033090,"version":"4.8.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejphar.2023.176089","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T21:36:44Z","timestamp":1697146604000},"page":"176089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Emerging links between FOXOs and diabetic complications"],"prefix":"10.1016","volume":"960","author":[{"given":"Urvi M.","family":"Parmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjiri P.","family":"Jalgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayush J.","family":"Kansara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha J.","family":"Oza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176089_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108515","article-title":"Curcumin reverses diabetic nephropathy in streptozotocin-induced diabetes in rats by inhibition of PKC\u03b2\/p66Shc axis and activation of FOXO-3a","volume":"87","author":"ALTamimi","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejphar.2023.176089_bib2","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.176089_bib3","first-page":"1","article-title":"Current pharmacological treatment of painful diabetic neuropathy: a narrative review","volume":"56","author":"Ardeleanu","year":"2020","journal-title":"M\u00e9d."},{"key":"10.1016\/j.ejphar.2023.176089_bib4","first-page":"1445","article-title":"Diabetic nephropathy - a review of the natural history, burden, risk factors and treatment","volume":"96","author":"Ayodele","year":"2004","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.ejphar.2023.176089_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jdi.12223","article-title":"Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting","volume":"5","author":"Bansal","year":"2014","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.ejphar.2023.176089_bib6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI60329","article-title":"Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice","volume":"122","author":"Battiprolu","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.176089_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/db08-0537","article-title":"FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats","volume":"58","author":"Behl","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.176089_bib8","first-page":"709","article-title":"Is autophagy associated with diabetes mellitus and its complications? A review","volume":"17","author":"Bhattacharya","year":"2018","journal-title":"EXCLI J"},{"key":"10.1016\/j.ejphar.2023.176089_bib9","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.96.13.7421","article-title":"Protein kinase B\/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1","volume":"96","author":"Biggs","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2023.176089_bib10","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.176089_bib11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.176089_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176089_bib13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.176089_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-020-0088-2","article-title":"Therapeutic strategies targeting FOXO transcription factors","volume":"20","author":"Calissi","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2023.176089_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2023.176089_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cub.2007.01.008","article-title":"Quick guide FOXO transcription factors","volume":"17","author":"Carter","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2023.176089_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejphar.2018.06.034","article-title":"Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets","volume":"833","author":"Dewanjee","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176089_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ajhp\/61.2.160","article-title":"Diabetic neuropathy: an intensive review","author":"Duby","year":"2004","journal-title":"Am. J. Heal. Pharm."},{"key":"10.1016\/j.ejphar.2023.176089_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101089","article-title":"P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response","volume":"42","author":"Dusabimana","year":"2020","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejphar.2023.176089_bib20","author":"Federation"},{"key":"10.1016\/j.ejphar.2023.176089_bib21","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejphar.2023.176089_bib22","first-page":"22","article-title":"Epidemiology of diabetes","volume":"47","author":"Forouhi","year":"2019","journal-title":"M\u00e9d."},{"key":"10.1016\/j.ejphar.2023.176089_bib23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.176089_bib24","first-page":"215","volume":"33","author":"He","year":"2004","journal-title":"Microvas. compl. diabet."},{"key":"10.1016\/j.ejphar.2023.176089_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2217\/14796694.2.1.83","article-title":"FOXO factors: a matter of life and death","volume":"2","author":"Huang","year":"2006","journal-title":"Future Oncol."},{"key":"10.1016\/j.ejphar.2023.176089_bib26","doi-asserted-by":"crossref","first-page":"35959","DOI":"10.1074\/jbc.M302804200","article-title":"FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics","volume":"278","author":"Jacobs","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176089_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-016-0361-1","article-title":"Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy","volume":"15","author":"Kandula","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2023.176089_bib29","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.dsx.2016.12.022","article-title":"Diabetes microvascular complications\u2014a clinical update","volume":"11","author":"Khalil","year":"2017","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.ejphar.2023.176089_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1507\/endocrj.KR-109","article-title":"Role of FoxO proteins in pancreatic \u03b2 cells","volume":"54","author":"Kitamura","year":"2007","journal-title":"Endocr. J."},{"key":"10.1016\/j.ejphar.2023.176089_bib31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/19328","article-title":"Direct control of the forkhead transcription faotor AFX by protein kinase B","volume":"398","author":"Kops","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176089_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4093\/dmj.2015.39.6.451","article-title":"Autophagy: a novel therapeutic target for diabetic nephropathy","volume":"39","author":"Kume","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.ejphar.2023.176089_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.120.316738","article-title":"KLF5 is induced by FOXO1 and causes oxidative stress and diabetic cardiomyopathy","author":"Kyriazis","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.176089_bib34","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/ijc.30840","article-title":"FOXO transcription factors at the interface of metabolism and cancer","volume":"141","author":"Link","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.176089_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10571-014-0147-5","article-title":"Resveratrol protects PC12 cells from high glucose-induced neurotoxicity via PI3K\/Akt\/FoxO3a pathway","volume":"35","author":"Liu","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.176089_bib36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00018-019-03297-w","article-title":"Current perspective on the regulation of FOXO4 and its role in disease progression","volume":"77","author":"Liu","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2023.176089_bib37","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2174\/138945011796150280","article-title":"FOXO1: a potential target for human diseases","volume":"12","author":"Lu","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2023.176089_bib38","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1113\/expphysiol.2012.068361","article-title":"The Akt-FoxO3a-manganese superoxide dismutase pathway is involved in the regulation of oxidative stress in diabetic nephropathy","volume":"98","author":"Lu","year":"2013","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2023.176089_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2019.103702","article-title":"Aucubin alleviates diabetic nephropathy by inhibiting NF-\u03baB activation and inducing SIRT1\/SIRT3-FOXO3a signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice","volume":"64","author":"Ma","year":"2020","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.ejphar.2023.176089_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/oxim.2.3.8916","article-title":"A fork in the path : developing therapeutic inroads with foxO proteins","volume":"2","author":"Maiese","year":"2009","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.176089_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111422","article-title":"GDF11 protects against glucotoxicity-induced mice retinal microvascular endothelial cell dysfunction and diabetic retinopathy disease","volume":"537","author":"Mei","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.176089_bib42","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2174\/138945011796150307","article-title":"The complex biology of FOXO","volume":"12","author":"Monsalve","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2023.176089_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000375235","article-title":"FOXO3: a major gene for human longevity - a mini-review","volume":"61","author":"Morris","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.ejphar.2023.176089_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3494289","article-title":"FOXO transcriptional factors and long-term living","volume":"2017","author":"Murtaza","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.176089_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1900\/RDS.2015.12.48","article-title":"Risk factors and comorbidities in diabetic neuropathy: an update 2015","volume":"12","author":"Papanas","year":"2015","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.ejphar.2023.176089_bib46","first-page":"1","article-title":"Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy","volume":"14","author":"Park","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2023.176089_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228895","article-title":"Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy","volume":"15","author":"Potilinski","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176089_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31491\/CSRC.2018.12.024","article-title":"LncRNA-H19 induces retinal m\u00fcller cell apoptosis via MiR-29b\/FOXO4 Axis in diabetic retinopathy","volume":"2","author":"Qiu-li","year":"2018","journal-title":"Clin. Surg. Res. Commun."},{"key":"10.1016\/j.ejphar.2023.176089_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0067126","article-title":"FoxO3a serves as a biomarker of oxidative stress in human lens epithelial cells under conditions of hyperglycemia","volume":"8","author":"Raju","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176089_bib50","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1111\/jcmm.15725","article-title":"Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways","volume":"24","author":"Ren","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2023.176089_bib51","doi-asserted-by":"crossref","first-page":"17179","DOI":"10.1074\/jbc.274.24.17179","article-title":"Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B","volume":"274","author":"Rena","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176089_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-physiol-021909-135931","article-title":"The FoxO family in cardiac function and dysfunction","volume":"72","author":"Ronnebaum","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2023.176089_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jfbc.13158","article-title":"Salidroside ameliorates diabetic nephropathy in rats by activating renal AMPK\/SIRT1 signaling pathway","volume":"44","author":"Shati","year":"2020","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.ejphar.2023.176089_bib54","doi-asserted-by":"crossref","first-page":"16741","DOI":"10.1074\/jbc.274.24.16741","article-title":"Negative regulation of the forkhead transcription factor FKHR by Akt","volume":"274","author":"Tang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176089_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn2294","article-title":"Glucose neurotoxicity","volume":"9","author":"Tomlinson","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2023.176089_bib56","series-title":"Biomedicine & Pharmacotherapy Melatonin Attenuates Oxidative Stress and Inflammation of M\u00fcller Cells in Diabetic Retinopathy via Activating the Sirt1 Pathway 137","author":"Tu","year":"2021"},{"key":"10.1016\/j.ejphar.2023.176089_bib57","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrm2190","article-title":"Stressing the role of FoxO proteins in lifespan and disease","volume":"8","author":"Van Der Horst","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.176089_bib58","doi-asserted-by":"crossref","DOI":"10.1900\/RDS.2006.3.108","article-title":"Causes and characteristics of diabetic cardiomyopathy","volume":"3","author":"Wang","year":"2006","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.ejphar.2023.176089_bib59","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbrc.2018.11.140","article-title":"Pyrroloquinoline quinine protects HK-2 cells against high glucose-induced oxidative stress and apoptosis through Sirt3 and PI3K\/Akt\/FoxO3a signaling pathway","volume":"508","author":"Wang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2023.176089_bib60","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/14712598.2018.1545836","article-title":"Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies","volume":"18","author":"Whitehead","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.ejphar.2023.176089_bib61","author":"Wong"},{"key":"10.1016\/j.ejphar.2023.176089_bib62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lfs.2017.11.030","article-title":"The regulation of FOXO1 and its role in disease progression","volume":"193","author":"Xing","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.176089_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165806","article-title":"Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db\/db mice","volume":"1866","author":"Xiong","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2023.176089_bib64","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1111\/jcmm.15418","article-title":"FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes","volume":"24","author":"Yan","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2023.176089_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00929","article-title":"New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.176089_bib66","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1002\/jcp.26946","article-title":"Exogenous hydrogen sulfide attenuates the development of diabetic cardiomyopathy via the FoxO1 pathway","volume":"233","author":"Ye","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2023.176089_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2017.05.001","article-title":"Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy","author":"Yerra","year":"2017","journal-title":"JNB (J. Nutr. Biochem.)"},{"key":"10.1016\/j.ejphar.2023.176089_bib68","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s12035-016-9824-3","article-title":"Adenosine monophosphate-activated protein kinase abates hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation","volume":"54","author":"Yerra","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.176089_bib69","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1080\/21655979.2022.2031413","article-title":"C1q\/tumor necrosis factor-related protein-3 (CTRP3) activated by forkhead box O4 (FOXO4) down-regulation protects retinal pericytes against high glucose-induced oxidative damage through nuclear factor erythroid 2-related factor 2 (Nrf2)\/Nuclear factor-kap","volume":"13","author":"Zeng","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.ejphar.2023.176089_bib70","article-title":"\u03b1-Melanocyte-Stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetes","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176089_bib71","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.7150\/thno.48561","article-title":"Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2023.176089_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/rapm-2020-101918","article-title":"SIRT3 alleviates neuropathic pain by deacetylating FoxO3a in the spinal dorsal horn of diabetic model rats","volume":"46","author":"Zhou","year":"2021","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.ejphar.2023.176089_bib73","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1002\/jcb.28252","article-title":"Knockdown of FOXO6 inhibits high glucose\u2013induced oxidative stress and apoptosis in retinal pigment epithelial cells","volume":"120","author":"Zhou","year":"2019","journal-title":"J. Cell. Biochem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923006015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923006015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:19:35Z","timestamp":1757978375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923006015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":72,"alternative-id":["S0014299923006015"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176089","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging links between FOXOs and diabetic complications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176089"}}